Many enzymes catalyse reactions that proceed through covalent acyl-enzyme (ester or thioester) intermediates 1 . These enzymes include serine hydrolases 2,3 (encoded by one per cent of human genes, and including serine proteases and thioesterases), cysteine proteases (including caspases), and many components of the ubiquitination machinery 4,5 . Their important acyl-enzyme intermediates are unstable, commonly having half-lives of minutes to hours 6 . In some cases, acyl-enzyme complexes can be stabilized using substrate analogues or active-site mutations but, although these approaches can provide valuable insight [7] [8] [9] [10] , they often result in complexes that are substantially non-native. Here we develop a strategy for incorporating 2,3-diaminopropionic acid (DAP) into recombinant proteins, via expansion of the genetic code 11 . We show that replacing catalytic cysteine or serine residues of enzymes with DAP permits their first-step reaction with native substrates, allowing the efficient capture of acyl-enzyme complexes that are linked through a stable amide bond. For one of these enzymes, the thioesterase domain of valinomycin synthetase 12 , we elucidate the biosynthetic pathway by which it progressively oligomerizes tetradepsipeptidyl substrates to a dodecadepsipeptidyl intermediate, which it then cyclizes to produce valinomycin. By trapping the first and last acyl-thioesterase intermediates in the catalytic cycle as DAP conjugates, we provide structural insight into how conformational changes in thioesterase domains of such nonribosomal peptide synthetases control the oligomerization and cyclization of linear substrates. The encoding of DAP will facilitate the characterization of diverse acyl-enzyme complexes, and may be extended to capturing the native substrates of transiently acylated proteins of unknown function.
Letter reSeArCH of acyl-enzyme intermediates that are linked through an amide bond (Fig. 1a, b) . Within peptides, the conjugate acid of the β-amino group of DAP has a reported pK a value of between 6.3 and 7.5 (compared with the conjugate acid of the ε-amino group of free lysine, which has a pK a of 10.5) 13 . This suggests that the β-amino group of DAP could act as a nucleophile, and may form amide bonds with the substrates of enzymes. The half-life of amides in aqueous solution is about 500 years 14 , so the amide analogues of labile thioester and ester intermediates should be substantially stabilized, such that subsequent reactions with nucleophiles or solvent should be severely attenuated or abolished (Fig. 1b) .
The secondary-metabolite-producing nonribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs) generate complex acyl-enzyme intermediates during their synthetic cycles 15 . These megaenzymes use thio-templated pathways to assemble small acyl molecules into a broad array of biologically active natural products, including antitumour compounds, antibiotics, antifungals and immunosuppressants (Extended Data Fig. 1 ). Unravelling their molecular mechanisms has been hampered by the challenge of characterizing their multiple acyl-enzyme intermediates at high resolution.
This challenge is exemplified by the thioesterase (TE) domains 16 from NRPS pathways that oligomerize and cyclize linear peptidyl substrates 17 , including the TE domain from valinomycin synthetase 12 ( Fig. 1c) . This enzyme-a two-protein, four-module NRPS-alternatively links hydroxy acids (from in situ reduction of α-keto acids) and amino acids into a tetradepsipeptide intermediate, which the thioesterase domain (Vlm TE) oligomerizes up to, but not beyond, the dodecadepsipeptide. Vlm TE then cyclizes the dodecadepsipeptide to release valinomycin 12, 18 (a potassium ionophore with antimicrobial, antitumoural and cytotoxic properties; Fig. 1c) . The oligomerizations and cyclization must be rapid enough to prevent substantial spontaneous hydrolysis to linear depsipeptides, which are useless side products.
High-resolution structures of acyl-TE intermediates in valinomycin biosynthesis could provide mechanistic insight into how thioesterases control substrate fate. A handful of high-resolution acyl-TE structures have been obtained, most notably with the polyketide pikromycin-forming TE and non-native substrate analogues 19 (Supplementary Data 1). These have helped to identify the putative oxyanion hole and demonstrated the interaction of the 'lid' element of the TE domain with the substrate. However, structural studies of TE domains have been hampered by several factors, especially the hydrolysis rates of acyl-TE intermediates 20, 21 , which are high by comparison with the crystallographic timescale.
Here we develop a strategy for the site-specific incorporation of DAP into recombinant proteins, and demonstrate the efficient capture of antibody (bottom gel); the experiment was performed in two biological replicates with similar results. We used the indicated enzymes (DAPRS and PylRS) with their cognate tRNA CUA and amino acids (6 and BocK (Nε-[(tert-butoxy)carbonyl]-l-lysine) together with an sfGFP150TAG reporter construct. b, Encoded 6 was photo-deprotected, leading to an intermediate, which spontaneously fragments to reveal DAP. c, Deprotection of 6 in sfGFP followed by electrospray ionization mass spectroscopy (ESI-MS) analysis. Green trace, purified GFP150 (6) Letter reSeArCH acyl-enzyme intermediates for a cysteine protease and Vlm TE. We elucidate the biosynthetic pathway for converting tetradepsipeptides to valinomycin, and structurally characterize deoxy-tetradepsipeptidyl-N-TE DAP and dodecadepsipeptidyl-N-TE DAP conjugates to provide insights into the first and last acyl-TE intermediates in the catalytic cycle of Vlm TE. Our results reveal how the fate of substrates may be determined by conformational changes in the TE domains of NRPSs that oligomerize and cyclize linear precursors.
The structural similarity of DAP (1) to cysteine and serine makes it challenging to discover an aminoacyl-tRNA synthetase that is selective for DAP in vivo. We therefore created five protected versions of DAP (2-6; Extended Data Fig. 2a ), for which we anticipated that the successful discovery of specific aminoacyl-tRNA synthetase/tRNA CUA pairs would enable site-specific incorporation into proteins. The subsequent post-translational deprotection 22, 23 would reveal DAP. We found that 2-5 accumulated in Escherichia coli at low concentrations (less than 10 μM; Extended Data Fig. 2b -e) and we were unable to evolve a synthetase for these noncanonical amino acids using several libraries of the orthogonal Methanosarcina barkeri (Mb) pyrrolysyl-tRNA synthetase (PylRS)/tRNA CUA Pyl pair 11 (Supplementary Methods). By contrast, 6 accumulated in E. coli at millimolar concentrations and we were able to evolve an MbPylRS variant (named DAPRS, containing mutations Y271C, N311Q, Y349F and V366C) for the site-specific incorporation of 6 (Extended Data Fig. 2f-h ). The DAPRS/tRNA CUA Pyl pair enabled the synthesis of green fluorescent protein (GFP) containing 6 at position 150 (GFP150(6); Fig. 2a ) in good yield 24 . Photodeprotection of GFP150 (6) and subsequent incubation converted 6 to 1 in GFP (Fig. 2b, c) .
Cysteine proteases, including the tobacco etch virus (TEV) protease, react with substrates through a catalytic cysteine to generate an intermediate in which the protease is linked to the amino-terminal portion of its substrate through a thioester 4 . We replaced the active-site cysteine 151 of TEV protease with DAP, by genetically encoding 6 and deprotecting it, creating TEV(C151DAP). Incubating TEV(C151DAP) with Ub-tev-His 6 , a model substrate in which the cleavage site recognized by TEV protease (tev) is flanked by ubiquitin (Ub) and a hexahistidine tag (His 6 ), led to cleavage of the His 6 tag from ubiquitin and formation of a covalently linked TEV(C151DAP)-Ub conjugate ( Fig. 2d and Extended Data Fig. 3a-c) . Control experiments demonstrated that the stable conjugate was dependent on DAP incorporation. Tandem mass spectrometry (MS/MS) demonstrated amide-bond formation between DAP and ubiquitin (Extended Data Fig. 3d ). These results demonstrate that substitution of the catalytic cysteine in TEV with DAP creates a protease that performs the first step of the protease cycle, releasing the carboxy-terminal fragment of the substrate and leaving the aminoterminal fragment covalently attached to the protease through a stable amide bond that is resistant to hydrolysis.
To gain insight into the function of the TE domain and to prepare it for use with the DAP system, we expressed and purified wild-type Vlm TE (TE wt ). We found that Vlm TE can use an N-acetylcysteine (SNAC) derivative of the native depsipeptide (tetradepsipeptidyl-SNAC, 7; Extended Data . This pathway is analogous to that used by the more canonical gramicidin S synthetase 17, 26 and we suggest that nearly all oligomerizing-cyclizing NRPSs (or PKSs 27 ) will use this synthetic scheme.
We next obtained the structure of Vlm TE wt (Extended Data Fig. 6 and Extended Data Table 1 ). It adopts the α/β-hydrolase fold typical of type I TE domains, with a canonical serine-histidine-aspartate catalytic triad 16 covered by the TE 'lid' . The lid is a mobile element with proposed roles that include substrate positioning and solvent exclusion 21, 28, 29 . The lid of Vlm TE is large, composed of an extended loop, three helices (Lα1-3, seen here as a bundle), a five-residue helix (Lα4), a long helix (Lα5) and another short helix (Lα6) (Extended Data Fig. 6a, b) . We obtained another structure of TE wt that differs only in the lid. In the first, the lid is nearly completely ordered, although the B factors are markedly higher for the Lα1-4 region, which makes almost no contact with the rest of the domain (Extended Data Fig. 6b ). In the second structure, Lα4-5 have similar positions to those in the first structure, whereas Lα3 is rotated 10° towards the active site and Lα1-2 are too disordered to model.
Incubating Vlm TE with depsipeptidyl-SNACs did not yield stable conjugates (Extended Data Fig. 6c) , and attempts to soak TE wt crystals with depsipeptidyl-SNACs failed to reveal interpretable ligand electron density in the active site or conformational changes. Others have reported similar setbacks when attempting to visualize acyl-enzyme complexes from SNAC molecules 20, 21 (Supplementary Data 1). We Tetradepsipeptidyl-SNAC 7
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Octadepsipeptidyl-SNAC 11 17, 26 . In the 'forward transfer' scenario, the distal hydroxyl group of tetradepsipeptidyl-O-TE (TE) attacks (dotted line) the thioester group in tetradepsipeptidyl-S-PCP (PCP), directly forming octadepsipeptidyl-O-TE (right). In the 'reverse' scenario, the distal hydroxyl group of tetradepsipeptidyl-S-PCP attacks the ester group in tetradepsipeptidyl-O-TE, forming octadepsipeptidyl-S-PCP (left), which would later be transferred onto the TE domain serine. Our data are consistent with the 'reverse' oligomerization scenario; see also Extended Data Fig. 5. conclude that acyl intermediates in valinomycin biosynthesis are not stable, and that it is exceptionally challenging to use wild-type Vlm TE to visualize biosynthetic intermediates.
We therefore produced Vlm TE in which the active-site serine 2463 was replaced by DAP (TE DAP ; Extended Data Fig. 7a-c ) in order to capture stable acyl-TE conjugates (Fig. 4) . To provide insight into the first acyl-thioesterase intermediate in the catalytic cycle of Vlm TE, we captured tetradepsipeptidyl-N-TE DAP : incubation of TE DAP with tetradepsipeptidyl-SNAC (7) led to production of a stable depsipeptidyl-TE DAP intermediate in greater than 60% yield (Extended Data  Fig. 7d ), and we did not observe valinomycin synthesis. However, remarkably, we did observe a small amount of octadepsipeptidyl-SNAC (11; Extended Data Fig. 5f, h ). 11 is probably formed by enzymecatalysed attack of the tetradepsipeptidyl-SNAC's hydroxyl group on the amide bond that links the tetradepsipeptide to TE DAP . The attack of a hydroxyl on an amide is analogous to the first reaction used by related serine proteases 30 , but it is surprising that this TE domain is capable of catalysing a more demanding chemical reaction (amide cleavage) than the reaction (ester hydrolysis) it evolved to perform. In an effort to enhance conjugate yield, we optimized the conditions for conjugating deoxy-tetradepsipeptidyl-SNAC 8 with TE DAP , which produced (in about 70% yield) the deoxy-depsipeptidyl-TE DAP conjugate (Fig. 4a) . The marginal solubility of these hydrophobic SNACs may limit the conjugation efficiency.
To determine the structure of the deoxy-tetradepsipeptidyl-N-TE DAP conjugate, we incubated TE DAP crystals with the deoxy-tetradepsipeptidyl-SNAC (8) . The resulting electron density shows somewhat weak but unambiguous density for an amide bond between DAP 2463 and l-valine 4 of the deoxy-tetradepsipeptide (Fig. 4c and Extended Data  Fig. 8a) . The carbonyl oxygen of the l-valine 4 is close to backbone amides of residues alanine 2399 and leucine 2464-the putative oxyanion hole 25 ( Fig. 4e ). There is also density for the next residue, l-lactic acid 3 (l-lac3), but it is insufficient to reliably model d-valine 2 and d-α-hydroxyisovaleric acid 1 (d-hiv1) as the deoxy-tetradepsipeptide arcs out, indicating substrate flexibility. The deoxy-tetradepsipeptide does not make any interactions with the lid, which is in a conformation nearly identical to that in the first TE wt (apo) structure ( Fig. 4g and Extended Data Fig. 6d) .
Next, we sought insight into the last acyl-TE intermediate in the catalytic cycle. Upon incubation of valinomycin and TE DAP , we captured dodecadepsipeptidyl-N-TE DAP in 65-100% yield, formed through a ring-opening reaction analogous to the reverse of the natural cyclization (Fig. 4b) . This reaction is thermodynamically favoured by virtue of amide-bond formation. Dodecadepsipeptidyl-TE DAP produced crystals in similar conditions to those of TE wt , but with a different morphology and belonging to two different space groups (H3 and P1, with two and six molecules per asymmetric unit, respectively; Extended Data Table 1 ). All eight crystallographically independent molecules of dodecadepsipeptidyl-TE DAP showed some density for the dodecadepsipeptide. Molecules P1_A-F and H3_A-B show strong density for four, three, two, two, two, two, three and one dodecadepsipeptide residues respectively ( Fig. 4d and Extended Data Fig. 8b-i) . Additional weaker density is present in some molecules, which could accommodate up to the full 12 residues (Extended Data Fig. 8j-l) ; in others, weaker density suggests multiple conformations for the distal residues, but they were not possible to definitively model. The modelled depsipeptides all follow a similar trajectory away from the active site. There is no consistent interaction between the depsipeptide beyond the l-valine residue attached to DAP and the TE domain (Fig. 4f, h) . Rather, each depsipeptide makes different contacts with the lid. The lid forms a semi-sphere-like pocket/steric barrier made up of helices Lα1, 3, 4 and 5, and the strand amino-terminal to Lα1. The lid of each crystallographically independent molecule of dodecadepsipeptidyl-TE DAP is in a similar but nonidentical position, and the loops between lid helices are disordered in most molecules (Fig. 4h) . This again highlights the mobility of the lid and explains why the conformation and extent of order of dodecadepsipeptides differ between molecules (Fig. 4h) . The semi-sphere-like barrier occurs only because of a major rearrangement of the lid in the dodecadepsipeptidyl-TE DAP structures with respect to the conformation of the lid seen in both the apo and tetradepsipeptidyl-bound structures of Vlm TE. 6ECD) is in a similar position to that seen in TE wt (6ECB; not shown). h, All crystallographically independent molecules of the dodecadepsipeptidyl-TE DAP (6ECE and 6ECF) are in a set of similar conformations, distinct from that seen in TE wt . i, Substantial conformational changes occur in lid helices Lα1-Lα4 between the conformations of tetradepsipeptidyl-TE DAP (g) and dodecadepsipeptidyl-TE DAP (h). See also Supplementary Videos 1 and 2. j, In the dodecadepsipeptidyl-TE DAP structure, the lid sterically prevents the dodecadepsipeptide from extending out in a linear fashion, instead favouring it curling back through this steric block and forming largely hydrophobic, non-specific interactions with the lid.
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Comparing the position of the Vlm TE lid in the apo and tetradepsipeptide-bound structures with the position of the lid in the dodecadepsipeptide-bound structures demonstrates and emphasizes its extreme mobility. To transition from one lid conformation to the other, helices Lα5-6 maintain their position, Lα3-4 rotate by about 45° and translocate roughly 13 Å, Lα2 translocates roughly 25 Å, and Lα1 shortens, translocates about 13 Å and rotates more than 90° in the opposite direction to Lα3-4 ( Fig. 4i and Supplementary Videos 1, 2) . This dramatic rearrangement means that the lid helices pack together in a markedly different manner in the apo/tetradepsipeptidyl-bound structure and in dodecadepsipeptidyl-bound conformations.
The distinct lid conformations directly influence the possible location of the depsipeptide. In the apo/tetradepsipeptide-bound conformation of the lid, the carboxyl terminus of Lα1 comes within 10 Å of serine/DAP 2463, leading the tetradepsipeptide to extend towards the TE core helix αE. In the dodecadepsipeptide-bound conformations of the lid, the loop adjacent to Lα1 blocks the location occupied by the tetradepsipeptide in the tetradepsipeptide-bound structure. Moreover, in the dodecadepsipeptide-bound structure the amino terminus of Lα1 forms part of the semi-sphere-like pocket. This pocket probably helps to curl the dodecadepsipeptide back towards serine/DAP 2463, entropically controlling cyclization as part of the oligomerization/ cyclization pathway (Fig. 4j, Extended Data Fig. 9 and Supplementary Discussion 2).
In summary, we have genetically encoded DAP in place of catalytic cysteine and serine residues to capture unstable thioester or ester intermediates as stable amide analogues. We have exemplified the utility of this approach for a cysteine protease and a thioesterase, and provided unique insight into intermediates in the synthesis of valinomycin: a massive lid rearrangement that is associated with the dodecadepsipeptidylbound Vlm TE reorients the substrate from its position during oligomerization and places it into a pocket that entropically controls cyclization. Importantly, the DAP system enables the formation of near-native acyl-enzyme complexes with widely used, reactioncompetent substrates (for example, native proteins containing protease sites), substrate analogues (here SNACs), and commercially available natural products (here valinomycin, and probably other cyclic products 25 ). We anticipate that the approach will be broadly applicable and may be extended to capturing native substrates of transiently acylated proteins of unknown function.
Reporting summary
Further information on experimental design is available in the Nature Research Reporting Summary linked to this paper.
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Extended Data Fig. 1 | Schematic representation and reaction cycle of  a canonical NRPS. a, Schematic representation of a generic type I NRPS. The square brackets denote a single module. b, i-vii, Synthetic cycle of a canonical elongation module. NRPSs assemble peptides from amino acyl and other small acyl building blocks using a modular and thio-templated logic. A canonical NRPS is composed of one module for every residue in the peptide product. The initiation module contains an adenylation (A) domain, which binds cognate acyl substrate and performs adenylation and transfer of that substrate as a thioester on the phosphopantetheine arm (PPE, shown as a wavy line) of a peptidyl carrier protein (PCP) domain, for transport between active sites. Each elongation module contains an A and a PCP domain, and also a condensation (C) domain, which condenses aminoacyl and peptidyl substrates bound to PCP domains, thus progressively elongating the nascent chain. Termination modules contain C, A and PCP domains, and a specialized terminating/offloading domain responsible for the release of the peptide in its final form. The most common and most versatile terminating domain in NRPSs is the TE domain. Similar TE domains terminate synthesis in polyketide and fatty acid synthases. PP i , diphosphate; aa, amino acid. Top, the sequence of the branched peptide subject to fragmentation. Fragmentation of the substrate chain is predicted to lead to a series of y ions (yellow) and a series of b ions (green); the ions from this chain are labelled as 'β' . Fragmentation of the TEV(C151DAP)-derived chain is predicted to lead to a series of y ions (blue) and a series of b ions (red); the ions from this chain are labelled as 'α' . Bottom, MS/MS spectra with peak assignments. Ions in the α-chain were assigned by treating DAP and the β-chain as a modification of known mass. Ions in the β-chain were manually assigned. The mass-spectrometry analysis was performed once. Fig. 7 | Expression and substrate conjugation to Vlm TE containing DAP at position 2463. a, Following expression and purification of Vlm TE DAP , the protein was loaded on an SDS-PAGE gel and Coomassie stained; the experiment was repeated in two biological replicates with similar results. b, The deprotection of 6 in TE DAP -strep was followed by ESI-MS analysis. Green trace, purified TE DAP -strep containing 6 at position 2463: expected mass 32,364. Fig. 8 | Electron density of the active site of covalent depsipeptidyl-TE DAP complexes. Unbiased mF o -DF c maps (green mesh, contoured at 2.5σ), calculated before depsipeptide residues were placed in the model. DAP (brown) and depsipeptide residues (cyan) are depicted as sticks. a, Tetradepsipeptidyl-TE DAP (PDB accession number 6ECD). b-g, Dodecadepsipeptidyl-TE DAP P 1 space-group structure (6ECF), with crystallographically independent molecules A to F shown in sequential order. h, i, Dodecadepsipeptidyl-TE DAP H 3 space group (6ECE), for crystallographically independent molecules A and B. j-l, Electron density of the active site of covalent depsipeptidyl-TE DAP complexes extends beyond modelled depsipeptides. Unbiased mF o -DF c maps (green mesh, contoured at 2.5σ), calculated before depsipeptide residues were placed in the model, for dodecadepsipeptidyl-TE DAP P 1 space-group structure, with crystallographically independent molecules A, B and D in sequential order. The observed electron density that extends beyond the modelled depsipeptides (cyan sticks) could accommodate extra depsipeptide residues in different orientations. However, unambiguous modelling into this density could not be achieved. 
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Software and code
Policy information about availability of computer code Data collection Diffraction data collection was performed at the Canadian LIght Source using the Macromolecular Crystallography Data Collector software and at the Advanced Photon Source using CONSOLE and RAPD.
Data analysis
Crystallography data were processed and analyzed using DIALS v1.10, CCP4 Suite v7.0 (including iMosflm, Pointless, Scala, Phaser, Aimless, Coot, REFMAC5, TopDraw), Phenix v1.13 (including phenix.refine, Phaser, Sculptor, AutoBuild), PyMOL v1.8.2. Mass spectrometry data were processed with Bruker Compass DataAnalysis v4.2 (including SmartFormula) or Agilent OpenLAB CDS software v2.3.
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